Understanding how DNA replication stress affects blood cell development and cancer
Replication stress in hematopoiesis and lymphomagenesis
This study is looking at how problems with DNA copying can affect blood cell development and possibly lead to cancer, helping us understand the genes and proteins involved so that patients might benefit from new treatments in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10532172 on NIH RePORTER |
What this research studies
This research investigates how DNA replication stress impacts the development of blood cells and the potential for cancer formation. It focuses on understanding the genes involved in responding to DNA damage and how these processes can lead to blood cell deficiencies and malignancies. By studying specific proteins that help repair DNA during replication stress, the research aims to uncover the mechanisms that contribute to hematologic cancers. Patients may benefit from insights into how their blood cell development is affected by DNA damage and the potential for targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of blood disorders or those at risk for hematologic malignancies.
Not a fit: Patients with solid tumors unrelated to blood cell development may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for blood cancers and related disorders.
How similar studies have performed: Other research has shown success in understanding DNA replication stress in cancer, indicating that this approach has potential for meaningful discoveries.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Eischen, Christine M. — Thomas Jefferson University
- Study coordinator: Eischen, Christine M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.